Medapp SA
WSE:MDA
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
0.18
0.38
|
| Price Target |
|
We'll email you a reminder when the closing price reaches PLN.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Medapp SA
Depreciation & Amortization
Medapp SA
Depreciation & Amortization Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Depreciation & Amortization | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
M
|
Medapp SA
WSE:MDA
|
Depreciation & Amortization
zł4.1m
|
CAGR 3-Years
43%
|
CAGR 5-Years
83%
|
CAGR 10-Years
N/A
|
|
|
S
|
Synektik SA
WSE:SNT
|
Depreciation & Amortization
zł16.4m
|
CAGR 3-Years
27%
|
CAGR 5-Years
26%
|
CAGR 10-Years
16%
|
|
|
E
|
Europejski Fundusz Energii SA
WSE:EFE
|
Depreciation & Amortization
zł0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Medapp SA
Glance View
MedApp SA engages in the provision of mobile marketing solutions in the field of medicine. The company is headquartered in Krakow, Woj. Malopolskie. The company went IPO on 2011-10-19. The firm provides a software application, named Carna Life, which is used in telemedicine sector. Carna Life serves as communication channel between doctors and patient. Carna Life is a telemedicine system that enables patients to upload test results and receive doctor's interpretation. The application operates in online (upload and download of data) and offline (review of data) mode. Carna Life provides statistics, graphic visualizations and tables with interpreted data. The firm is controlled by Moonrock Enterprise SA.
See Also
What is Medapp SA's Depreciation & Amortization?
Depreciation & Amortization
4.1m
PLN
Based on the financial report for Jun 30, 2024, Medapp SA's Depreciation & Amortization amounts to 4.1m PLN.
What is Medapp SA's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 5Y
83%
Over the last year, the Depreciation & Amortization growth was 164%. The average annual Depreciation & Amortization growth rates for Medapp SA have been 43% over the past three years , 83% over the past five years .
You don't have any saved screeners yet
